Elecsys CMV IgG
FDA 510(k) K220911 · Roche Diagnostics
510(k) numberK220911
Submission
- Device name
- Elecsys CMV IgG
- Applicant
- Roche Diagnostics
Indianapolis, IN, US - Received
- March 29, 2022
- Decision date
- October 12, 2022
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- LFZ – Enzyme Linked Immunoabsorbent Assay, Cytomegalovirus
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 866.3175
- Specialty
- Microbiology
Other 510(k)s with product code LFZ
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K220949 | Architect CMV IgGLFZ · Traditional | Abbott Laboratories | 10/27/2022SE |
| K181213 | ADVIA Centaur CMV IgG and ADVIA Centaur CMV IgG Quality ControlLFZ · Traditional | Siemens Healthcare Diagnostics, Inc. | 07/30/2018SE |
| K163569 | Elecsys CMV IgMLFZ · Traditional | Roche Diagnostics | 03/17/2017SE |
| K162969 | LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control SetLFZ · Special | DiaSorin, Inc. | 01/06/2017SE |
| K142133 | Elecys CMV Igm Immunoassay; Elecys Precicontrol CMV IgmLFZ · Traditional | Roche Diagnostics | 10/24/2014SE |
| K131605 | Elecsys Precicontrol CMV Igg, Elecsys CMV Igg ImmunoassayLFZ · Traditional | Roche Diagnostics | 02/28/2014SE |
| K040290 | Diasorin Liaison CMV Igm/IggLFZ · Traditional | Diasorin S.P.A | 06/01/2005SE |
| K993952 | Immulite 2000 CMV Igg, Model L2KCV2, L2KCV6LFZ · Special | Diagnostic Products Corp. | 12/16/1999SE |
| K982485 | Seraquest CMV IgmLFZ · Traditional | Quest Intl., Inc. | 01/13/1999SE |
| K984139 | The Aptus (Automated) Application of the CMV Igg Elisa Test System. an Enzyme Linked…LFZ · Traditional | Zeus Scientific, Inc. | 01/11/1999SE |
More from Zeus Scientific, Inc.
| 510(k) | Device | Decision |
|---|---|---|
| K261686 | Elecsys Phospho-Tau (217P) PlasmaSET · Traditional | 08/19/2026SE |
| K252323 | cobas pulse blood glucose monitoring systemPZI · Dual Track | 06/12/2026SE |
| K252431 | Elecsys CalcitoninJKR · Traditional | 04/24/2026SE |
| K252280 | Elecsys Anti-SARS-CoV-2 SQVP · Traditional | 04/13/2026SE |
| K260049 | Elecsys Anti-HBc IgMSEI · Traditional | 04/07/2026SE |
| K260048 | Elecsys Anti-HAV IgMLOL · Traditional | 04/07/2026SE |
| K260046 | Elecsys Anti-HBc IISEI · Traditional | 04/07/2026SE |
| K260026 | Tina-quant Cardiac high sensitivity CRP IIINQD · Traditional | 04/02/2026SE |
| K253491 | ISE indirect K for Gen.2; ISE indirect Na for Gen.2; ISE indirect Cl for Gen.2; cobas…CEM · Traditional | 02/12/2026SE |
| K253490 | Glucose HK Gen.3; ONLINE DAT Methadone II; cobas pro integrated solutionsCFR · Traditional | 02/12/2026SE |
Questions and answers
When was Elecsys CMV IgG cleared by the FDA?
Elecsys CMV IgG (K220911) received a 510(k) decision of Substantially Equivalent on October 12, 2022, 197 days after the submission was received.
What is the product code of K220911?
The FDA product code is LFZ – Enzyme Linked Immunoabsorbent Assay, Cytomegalovirus, a Class II (moderate risk) device regulated under 21 CFR 866.3175.